ACTION

International Respect For Chickens Day Celebrates the Joy of Chickens

Retrieved on: 
Monday, May 1, 2023
Friends, Atmosphere, Life, Death, Social Life, Multimedia, United Poultry Concerns, Egg as food, Encyclopædia Britannica, Bird, Family, ACTION, Poultry farming, Chicken

MACHIPONGO, Va., May 1, 2023 /PRNewswire/ -- On May 4, animal advocates celebrate International Respect for Chickens Day. Launched by United Poultry Concerns in 2005, International Respect for Chickens Day celebrates chickens throughout the world and protests their suffering and abuse in agribusiness, experimental research, cockfighting, and other cruelties. May is International Respect for Chickens Month.

Key Points: 
  • MACHIPONGO, Va., May 1, 2023 /PRNewswire/ -- On May 4, animal advocates celebrate International Respect for Chickens Day .
  • Launched by United Poultry Concerns in 2005, International Respect for Chickens Day celebrates chickens throughout the world and protests their suffering and abuse in agribusiness, experimental research, cockfighting, and other cruelties.
  • May is International Respect for Chickens Month.
  • United Poultry Concerns urges people to celebrate chickens on the planet instead of the plate, and to make every day Respect for Chickens Day.

New Data Shows Vast Majority of Canadians Believe Global Sexual and Reproductive Health and Rights Should be a Federal Government Priority

Retrieved on: 
Monday, March 20, 2023
Global Affairs Canada, Policy advocacy, Reproductive rights, Face, Diplomacy, Disability, Birth, Woman, SRHR, Abortion, Risk, Ageing, CANADA, Annual report, Health, Death, Action Canada, ACTION, Birth control, Policy

Notably, the data shows that Canadians believe supporting SRHR is just as important around the world as it is at home.

Key Points: 
  • Notably, the data shows that Canadians believe supporting SRHR is just as important around the world as it is at home.
  • "This polling data comes at a time when sexual and reproductive rights are facing increased attacks in the U.S. and globally," says Kelly Bowden, Director of Policy, Advocacy, and Government Relations at Action Canada for Sexual Health and Rights.
  • While the polling data shows that Canadians care about global sexual and reproductive health and rights, it also reveals that nearly half of Canadians (47%) don't know about Canada's role in achieving those rights.
  • ACTION CANADA FOR SEXUAL HEALTH & RIGHTS is a progressive, pro-choice charitable organization committed to advancing and upholding sexual and reproductive health and rights in Canada and globally.

Nano Dimension (“NANO”) Reiterates that Shareholder Meeting Called by Murchinson Ltd. is Illegal & Invalid. Urges Shareholders to:

Retrieved on: 
Tuesday, March 7, 2023
Growth, Waltham, NO, Share repurchase, ANY, NANO, THIS, ACTION, 3D printing, TIME, Holding company, Management

Waltham, Mass, March 07, 2023 (GLOBE NEWSWIRE) --  Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, today reiterated that the shareholder meeting called by Bistricer/Murchinson Ltd. (“Bistricer/Murchinson”) is invalid.

Key Points: 
  • Company Will Inform Shareholders If and When a Valid and Duly Called Shareholder Meeting Will be Held.
  • NANO filed a lawsuit seeking a declaratory judgment that the Bistricer/Murchinson’s meeting is illegal and seeking $10 million damages in relation to their illegal and bad faith actions.
  • The Nano Dimension Board of Directors urges shareholders to take NO ACTION AND DISREGARD ANY MATERIALS OR WHITE PROXY CARDS THEY MAY RECEIVE.
  • Lazard Frères & Co., LLC is acting as Nano Dimension’s financial advisor, and Sullivan & Worcester LLP is serving as legal advisor.

Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update

Retrieved on: 
Thursday, March 2, 2023
Patient, Pediatrics, University of California, San Francisco, Glioma, Doctor of Philosophy, PNOC, Glioblastoma, ONC201, Central nervous system, Progression-free survival, Human, University, CNS, Malignancy, Conference call, Conference, DRD2, Neurosurgery, HGG, Emergent, Neoplasm, Bangladesh Technical Education Board, IDMC, MD, Sale, NIH, Brain, ACTION, Research, Consortium, MAS, UCSF, Pharmaceutical industry, Medical imaging, Video game, Cryptocurrency, Neurology

DURHAM, N.C., March 02, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today reported financial results for the fourth quarter and full-year ended December 31, 2022 and provided an operational update.

Key Points: 
  • Following the monetization of TEMBEXA, we have a strong balance sheet to fully fund Chimerix into 2027, including through potential approval of ONC201.
  • “As we look to 2023, we are making tremendous progress and continuing our strong execution to advance ONC201 towards regulatory approval.
  • General and administrative expenses increased to $5.3 million for the fourth quarter of 2022, compared to $5.2 million for the same period in 2021.
  • Chimerix will host a conference call and live audio webcast to discuss fourth quarter and full-year 2022 financial results and provide a business update today at 8:30 a.m.

EQS-News: Steinhoff International Holdings N.V. : Steinhoff launches Accelerated Placement of ordinary shares in Pepco Group N.V.

Retrieved on: 
Thursday, February 2, 2023
ACT, JOINT, United Kingdom, SUM, LAWS, FORM, Placement, JSE Limited, PEPCO, Frankfurt Stock Exchange, FINANCIAL, NO, THIS, FUTURE, PRICE, JP, SALE, FOR, EUROPEAN UNION, OR, NOT, WITH, Steinhoff, IT, RISK, UP, NUMIS, SELL, WHO, BY, ALL, AFRICA, News, NOR, ACTION, AS, PAST, LOSING, ANY, EEA, INCLUDE, China Aerospace International Holdings, AN, Academic acceleration, J. P. Morgan, Security (finance), Property management, Life insurance, AND, Dealz, Pepco, UNITED STATES, EU

Steinhoff International Holdings N.V. : Steinhoff launches Accelerated Placement of ordinary shares in Pepco Group N.V.

Key Points: 
  • Steinhoff International Holdings N.V. : Steinhoff launches Accelerated Placement of ordinary shares in Pepco Group N.V.
  • Steinhoff launches Accelerated Placement of ordinary shares in Pepco Group N.V.
    Steinhoff International Holdings N.V. (the “Company”, together with its subsidiaries, “Steinhoff” or the “Steinhoff Group”) announces that the Steinhoff Group has decided to launch an accelerated placement of ordinary shares in Pepco Group N.V. (“Pepco Group”) which are held through IBEX Retail Investments (Europe) Limited (formerly Pepco Holdco Limited) (the “Seller”), an indirect wholly owned subsidiary of the Company.
  • The Steinhoff Group intends to sell approximately 34.5 million ordinary shares (the “Placement Shares”) in the capital of Pepco Group, through a placement to institutional investors (the “Placement”).
  • The Placement Shares represent up to 6% of Pepco Group’s issued share capital, subject to the final terms of the Placement.

EQS-News: Steinhoff International Holdings N.V. : Result of Accelerated Placement of ordinary shares in Pepco Group N.V.

Retrieved on: 
Thursday, February 2, 2023
ACT, JOINT, SUM, LAWS, FORM, Placement, JSE Limited, PEPCO, Frankfurt Stock Exchange, FINANCIAL, NO, THIS, FUTURE, PRICE, JP, SALE, Sale, FOR, EUROPEAN UNION, OR, NOT, WITH, Steinhoff, IT, RISK, UP, EUR, NUMIS, SELL, WHO, BY, ALL, AFRICA, News, NOR, T+2, ACTION, AS, PAST, LOSING, ANY, EEA, INCLUDE, China Aerospace International Holdings, AN, Academic acceleration, PLN, J. P. Morgan, Security (finance), Property management, Life insurance, AND, UNITED STATES, EU

Steinhoff International Holdings N.V. : Result of Accelerated Placement of ordinary shares in Pepco Group N.V.

Key Points: 
  • Steinhoff International Holdings N.V. : Result of Accelerated Placement of ordinary shares in Pepco Group N.V.
  • The Placement was upsized from its launch size of approximately 34.5 million ordinary shares due to investor demand.
  • Following closing of the Placement, the Company will indirectly hold 415,594,616 ordinary shares, representing approximately 72.3% of Pepco Group’s issued share capital.
  • The ordinary shares in Pepco Group retained by Steinhoff following the Placement will be subject to a 90-day lock-up period, subject to customary exemptions.

Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update

Retrieved on: 
Thursday, December 8, 2022
ONC201, Conference, Pakistan Society of Neuro-Oncology, Prevalence, Food, FDA, Probability, Literature, Food and Drug Administration, Radiation, Emergent, Survival, Bevacizumab, HIV disease progression rates, Glioma, Disease, SNO, ACTION, Patient, Physician, Pharmaceutical industry

DURHAM, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today provided an operational update and announced the successful launch of the ONC201 Phase 3 ACTION study at the recent Society for Neuro Oncology (SNO) Conference, which took place November 16-20, 2022 in Tampa, Florida.  

Key Points: 
  • “We are very excited to announce the timely opening of enrollment for the ACTION study at SNO.
  • Physicians have already initiated the referral process to ensure recently diagnosed patients have the potential to enroll in the study.
  • “Following recent interactions with FDA, we believe the best path to approval for ONC201 is successful execution of the randomized controlled ACTION study and we are focusing resources appropriately.
  • Forward-looking statements include those relating to, among other things, the initiation and probability of success of the Phase 3 ACTION study.

Prime Minister strengthens ties with the French-speaking world at the Sommet de la Francophonie

Retrieved on: 
Sunday, November 20, 2022
ASEAN, Cholera, President of the Swiss Confederation, Cyberattack during the Paris G20 Summit, Growth, ASEAN Summit, Face, Democracy, Climate change, Woman, Summit, Government, Environment, Empowerment, Corruption, G20, ACTION, Organization, APEC, Aggression, D-8 Organization for Economic Cooperation, Offense, Education, Research, 16 Days of Activism against Gender-based Violence, Sommets du cinéma d'animation, Cultural diversity, Food, Agence universitaire de la Francophonie, Indo-Pacific, Freezing, Premier of Quebec, Foreign Affairs, Violence, Language, Public relations, Agriculture, Animal, Drug, Organisation internationale de la Francophonie

At the Sommet de la Francophonie, Prime Minister Trudeau reaffirmed Canada's commitment to remaining a strong partner for fellow Francophonie members and governments and continuing to support La Francophonie's institutions.

Key Points: 
  • At the Sommet de la Francophonie, Prime Minister Trudeau reaffirmed Canada's commitment to remaining a strong partner for fellow Francophonie members and governments and continuing to support La Francophonie's institutions.
  • At the Summit, the Prime Minister reiterated Canada's commitment to promote democracy and human rights in Francophonie countries and around the world.
  • This is the third Sommet de la Francophonie attended by Prime Minister Trudeau.
  • This was the 18th Sommet de la Francophonie, and the first to be held in four years.

Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update

Retrieved on: 
Thursday, November 3, 2022
Company, Private Securities Litigation Reform Act, Exercise, Sale, Association, GLOBE, Probability, Neuro, FDA, Investor, Population, Safety, ACTION, Conference, Biomedical Advanced Research and Development Authority, HIV disease progression rates, Conference call, NDA, Research, U.S. Securities and Exchange Commission, Data, New Drug Application, Forward-looking statement, ID, Acceleration, Glioma, NASDAQ, Development, Human, Agency, Society, Emergent, Patient, BARDA, Pharmaceutical industry, Video game, Security (finance), ONC201

DURHAM, N.C., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today reported financial results for the third quarter ended September 30, 2022 and provided an operational update.

Key Points: 
  • In the meantime, we remain disciplined with spend across the organization as we complete the transition of TEMBEXAto Emergent.
  • Chimerix recorded a net loss of $18.6 million, or $0.21 per basic and diluted share, for the third quarter of 2021.
  • General and administrative expenses increased to $5.3 million for the third quarter of 2022, compared to $4.9 million for the same period in 2021.
  • Chimerix will host a conference call and live audio webcast to discuss third quarter 2022 financial results and provide a business update today at 8:30 a.m.

Alcoa Foundation celebrates 70-year legacy

Retrieved on: 
Tuesday, November 1, 2022
Professional Services, Machine Tools, Metalworking & Metallurgy, Philanthropy, Other Natural Resources, Mining, Minerals, Natural Resources, Other Manufacturing, Fund Raising, Steel, Foundation, Other Philanthropy, Environmental, Social and Governance (ESG), Manufacturing, Partnership, Organization, Research, Poverty, Program, Food, Workforce, Volta Aluminum Company, Homelessness, Education, ACTION, Foundation, History, Topical steroid withdrawal, Environment, Sustainability, Pharmaceutical industry, Aluminium, Tourism

This year Alcoa Foundation celebrates its 70th anniversary, heralding a legacy of giving that has benefitted non-profit organizations and Alcoa communities for seven decades.

Key Points: 
  • This year Alcoa Foundation celebrates its 70th anniversary, heralding a legacy of giving that has benefitted non-profit organizations and Alcoa communities for seven decades.
  • Alcoa Foundation was founded in 1952 with a $16.9 million endowment by the Aluminum Company of America (renamed Alcoa Inc. in 1999).
  • Following the legal separation of Alcoa into two standalone companies in 2016, the original Alcoa Foundation was divided, and a new Alcoa Foundation associated with Alcoa Corporation was launched.
  • Learn more about Alcoa Foundation at Alcoa Foundation and follow @AlcoaFoundation on Facebook and Twitter .